Compare WAL & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAL | TECH |
|---|---|---|
| Founded | 1994 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.2B |
| IPO Year | 2005 | 1989 |
| Metric | WAL | TECH |
|---|---|---|
| Price | $85.55 | $59.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 14 |
| Target Price | ★ $99.64 | $71.23 |
| AVG Volume (30 Days) | 845.5K | ★ 1.6M |
| Earning Date | 01-26-2026 | 02-04-2026 |
| Dividend Yield | ★ 1.81% | 0.54% |
| EPS Growth | ★ 24.99 | N/A |
| EPS | ★ 8.09 | 0.49 |
| Revenue | ★ $3,189,400,000.00 | $1,216,732,000.00 |
| Revenue This Year | $16.21 | $2.33 |
| Revenue Next Year | $9.07 | $7.05 |
| P/E Ratio | ★ $10.39 | $120.82 |
| Revenue Growth | ★ 9.57 | 3.85 |
| 52 Week Low | $57.05 | $46.01 |
| 52 Week High | $94.40 | $79.28 |
| Indicator | WAL | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 53.87 | 50.87 |
| Support Level | $85.14 | $58.54 |
| Resistance Level | $88.09 | $59.64 |
| Average True Range (ATR) | 1.65 | 1.46 |
| MACD | -0.45 | 0.11 |
| Stochastic Oscillator | 44.54 | 80.40 |
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.